Placement Announced

ADARx Pharmaceuticals placement

US$89m raised

Announced 24 Sep 2026 · NASDAQ: ADRX · US$17.00 cash per share

Advisers

ADARx Pharmaceuticals

Issuer

Not disclosed

Issuer
ADARx Pharmaceuticals
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.